Muscle Strength and Outcome Measures for Upper Limb Function in Adults With Myotonic Dystrophy Type 1: A Cross‐Sectional Study
European Journal of Neurology · 2026-11 · 33 (11)
DOI: 10.1111/ene.70799 ↗At a glance
Journal article in European Journal of Neurology, published online on 2026-10-30. Written by Hanne Ludt Fossmo and 5 co-authors. Institution: Department of Public Health Sciences and Interdisciplinary Health Sciences, Institute of Health and Society, Faculty of Medicine, University of Oslo,…. Major MEDLINE topics: Myotonic Dystrophy, Upper Extremity, Muscle Strength. 35 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Norwegian Centre for Rare Diseases research fund, Norwegian Neuromuscular Diseases Association research fund, Sophie and Leif Torps research fund for Myotonic Dystrophy.
Abstract (original language)
Background
Myotonic dystrophy Type 1 (DM1) is a multisystem neuromuscular disorder with progressive distal and proximal weakness, including in the upper limbs. Limited research has been conducted on hand function and outcome measures.
Methods
Eighty nine adult DM1 participants were included in this cross‐sectional study. The study describes upper limb strength and function and examines associations between motor impairments and clinical outcome measures, including comparing strength measurement methods. Disease severity was classified with the muscular impairment rating scale (MIRS) and the Brooke upper extremity scale was used as a classification scale of upper limb function. Muscle strength was measured using handheld dynamometers, and fine motor function with the Nine‐Hole Peg Test and Nut and Bolt task. Upper limb function was rated with the Revised Upper Limb Module and global motor function with the Motor Function Measure 32. Patient‐reported outcome measures included ABILHAND‐NMD, ACTIVLIM, and the Myotonia behavior scale.
Results
Participants showed a wide spectrum of motor impairment from minimal distal to severe proximal weakness. Strength measures correlated significantly with functional tests, while PROMs reflected perceived limitations but showed ceiling effects. Disease duration correlated with muscle strength and upper limb function, while age and subtype were less important. Myotonia severity showed only weak correlation with functional outcomes.
Conclusion
No single measure fully captures upper limb function in DM1. A combination of strength testing, dexterity tasks, and PROMs provides a multidimensional assessment framework. Muscle strength assessment remains essential, and these findings support integrating multiple standardized measures for clinical trial endpoints and therapeutic evaluation in DM1.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Public Health Sciences and Interdisciplinary Health Sciences, Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway.
- Section for Rare Neurological Disorders and EMAN, Department of Neurology, Oslo University Hospital, Oslo, Norway.
- Norwegian Center for Rare Diseases, Frambu, Siggerud, Norway.
- Vikersund Rehabilitation Center, Vikersund, Norway.
- Nordmøre and Romsdal Hospital, Hjelset, Norway.
- Department of Neurology, Haukeland University Hospital, Bergen, Norway.
ORCID profiles: Hanne Ludt Fossmo, Hilde Stendal Robinson, Jan C Frich, Kristin Ørstavik
Funding
- Norwegian Centre for Rare Diseases research fund
- Norwegian Neuromuscular Diseases Association research fund
- Sophie and Leif Torps research fund for Myotonic Dystrophy
Cite
APA
Fossmo, H. L., Robinson, H. S., Bjåstad, K. G., Varhaug, K. N., Frich, J. C., & Ørstavik, K. (2026). Muscle Strength and Outcome Measures for Upper Limb Function in Adults With Myotonic Dystrophy Type 1: A Cross‐Sectional Study. European Journal of Neurology, 33(11). https://doi.org/10.1111/ene.70799
Vancouver
Fossmo HL, Robinson HS, Bjåstad KG, Varhaug KN, Frich JC, Ørstavik K. Muscle Strength and Outcome Measures for Upper Limb Function in Adults With Myotonic Dystrophy Type 1: A Cross‐Sectional Study. European Journal of Neurology. 2026;33(11). doi:10.1111/ene.70799
BibTeX
@article{Fossmo2026,
author = {Fossmo, Hanne Ludt and Robinson, Hilde Stendal and Bjåstad, Karianne Grüner and Varhaug, Kristin Nielsen and Frich, Jan C and Ørstavik, Kristin},
title = {Muscle Strength and Outcome Measures for Upper Limb Function in Adults With Myotonic Dystrophy Type 1: A Cross‐Sectional Study},
journal = {European Journal of Neurology},
year = {2026},
volume = {33},
number = {11},
doi = {10.1111/ene.70799}
}
EUVIMED